Momenta Pharmaceuticals, Inc. (MNTA)

[flatlander_60048]

Personally I'm betting on FDA approval of m-copax before t-enox. Of course the patent litigation or settlement will have to run its course.

The annual 15% price increases on copax underscores my investment in MNTA. I think that there will be significant public pressure to get cheaper alternatives to market quicker as austerity measures come to this Country. Look at what a tough line NICE has drawn in the UK.

Efficiency and cost controls have been my investing themes for 2011 and 2012. MNTA and Nuance have worked out well. I also invested in FSYS thinking that an energy policy which emphasized natural gas made too much sense (environmentally, economically, etc.). This one has not played out.

I now believe that an important exception to the cost savings investment theme is in energy. The lobbying and political will is simply to strong for this country to take actions that are in its best interest. Hence we go year after year without an energy plan.


FL